Loading page content…
Loading page content…
Loading contract search results…
Loading contract details…
| Source: | Find a Tender Service (FTS) |
| Notice Type: | Pipeline / planning |
| Buyer: | NHS England |
| Main Category: | Services |
| Procurement Method: | — |
| Tender Status: | Pre-tender |
| Estimated Value (ex. VAT): | £30,000,000 |
| Estimated Value (inc. VAT): | £30,000,000 |
| Release Date: | 8 April 2026 |
| Application Deadline: | 13 April 2026 |
| Contract Start Date: | 31 March 2027 (Estimated) |
| Contract End Date: | 31 March 2030 (Estimated) |
| Contract Duration: | 3.1 years |
| Procurement ID (OCID): | ocds-h6vhtk-04ff2c |
| Notice Reference: | 031969-2026 |
All 4 notices for this procurement, oldest first.
National Specialist Medicines Service (NSMS) 2026-29
National Specialist Medicines Service (NSMS) 2026-29
National Specialist Medicines Service (NSMS)
National Specialist Medicines Service (NSMS)
Ready to bid on this contract?
BidWriter AI writes your tender response in minutes — import this contract in one click.
View Original Notice
Access the full notice on the official portal
NHS England is commissioning the National Specialist Medicines Service (NSMS) 2027-2030 contract. The contract holders will support in the implementation of national policies and priorities in medicines use and safety by developing cost effective standardised tools and processes that can be adopted/integrated locally. It will provide expert clinical quality assurance in medicines technical services and supports the NHS to get best value optimisation from the medicines budgets. In addition, it will provide clinical support for frontline service delivery in relation to medicines and to enable strategic commissioning of medicines related services. The NSMS will provide essential information on clinical and cost effectiveness use of medicines and their supply at local and national level to ensure patient access to essential treatment to a range of stakeholders and citizens. The premise of the contract is that these activities can avoid duplication at local level giving local clinicians more time for their patients and that opportunities to improve quality and value are taken up comprehensively. This preliminary market engagement session is due to be held on the 14th April 2026 between 1-2pm, where details of the Tender timetable will be made available, however, we will launch the ITT following the May elections and it will be out in the market for approximately 60 days to allow amply time for interested bidders to form a response. All parties interested in attending the session should register their interest by sending an email to jacqueline.powell9@nhs.net by 1pm Monday 13 April 2026. Please note up to a maximum of 3 attendees per supplier is permitted. When registering your interest, please ensure name and email address for all attending are provided, as a Teams invite will be sent to those registered. Please DO NOT forward the Teams invite on to any other party than those names provided. If unable to attend this session, a transcript will be made available upon request. Participation (or non participation) will not advantage or disadvantage suppliers in any future procurement.
Published contracts in the last 12 months
1,882
total contracts
£78609.7m
total value
£107,832,301
average contract size
Typical categories
Onasemnogene Abeparvovec Intravenous (Zolgensma®) Service & Onasemnogene Abeparvovec Intrathecal (OAV101 IT) Service
NHS England · WAC-607011
Percutaneous transluminal renal sympathetic denervation for resistant hypertension
NHS England · WAC-606399
NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets
NHS England · WAC-606474
Pipeline status
Not addedImports the contract into your BidWriter pipeline · Qualify before you commit to bid
Application Deadline
13 April 2026
Closed
Estimated Value
£30,000,000
Need help writing this bid?
Our specialists write winning tender responses. Free consultation, no obligation.
Book a free consultation →